🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PF-06700841 is a dual Tyrosine kinase 2 (TYK2) Janus kinase 1 (JAK1) inhibi...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2019-01-07
Trial ID
NCT03765554
Treatments Being Tested
Alopecia could be subdivided into two main groups of diseases: non-scarring...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2021-05-19
Trial ID
NCT05076006
Treatments Being Tested
This is a Phase 2b, randomized, double blind, parallel group, multicenter s...
Status
Completed
Location
Marvel Research, LLC
Start Date
2018-11-26
Trial ID
NCT03715829
This Phase 1 study will assess the pharmacokinetic effect of multiple doses...
Status
Completed
Location
Quotient Sciences Screening Office
Start Date
2020-08-24
Trial ID
NCT04267250
Treatments Being Tested
An open-label, fixed-sequence, 2-period study to investigate the effect of ...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2019-09-24
Trial ID
NCT04090047
Treatments Being Tested
This study is a phase 1 study of PF-06700841. PF-06700841 is being develope...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2017-08-16
Trial ID
NCT03236493
Treatments Being Tested
The main purpose of the study is to determine if PF-06700841 is safe and we...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2014-11
Trial ID
NCT02310750
Treatments Being Tested